A DNA nanomachine selectively targets skin cancer by detecting microRNA-7, activating phototherapy and releasing chemotherapy ...

while MiRNA was hit by the failure of its lead cancer programme and merged with Synlogic in 2017, diverting its cash reserves to microbiome candidates. Regulus meanwhile remains a microRNA player ...

A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target ...

In April 2021, they showed that their device can also detect urinary microRNA profiles ... to date is in early cancer and minimal residual disease detection after treatment, further research ...

TTX-MC138, designed to inhibit microRNA-10b (miR-10b), is considered ... and target a range of genetic factors relevant to ...